Výsledky vyhledávání - Evan J. Lipson
- Zobrazuji výsledky 1 - 20 z 62
- Přejít na další stránku
-
1
Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma Autor Evan J. Lipson, Charles G. Drake
Vydáno 2011Revisão -
2
-
3
-
4
-
5
-
6
-
7
-
8
Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade Autor Evan J. Lipson, Victor E. Velculescu, Theresa S. Pritchard, Mark Sausen, Drew M. Pardoll, Suzanne L. Topalian, Luis A. Díaz
Vydáno 2014Artigo -
9
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade Autor Evan J. Lipson, Mohammed Lilo, Aleksandra Ogurtsova, Jessica Esandrio, Haiying Xu, Patricia Brothers, Megan D. Schollenberger, William H. Sharfman, Janis M. Taube
Vydáno 2017Artigo -
10
-
11
-
12
Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series Autor Jaclyn LoPiccolo, Megan D. Schollenberger, Sumia Dakhil, Samuel Rosner, Osama Ali, William H. Sharfman, Ann W. Silk, Shailender Bhatia, Evan J. Lipson
Vydáno 2019Artigo -
13
Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen Autor Laura C. Cappelli, Julie R. Brahmer, Patrick M. Forde, Dung T. Le, Evan J. Lipson, Jarushka Naidoo, Lei Zheng, Clifton O. Bingham, Ami A. Shah
Vydáno 2018Artigo -
14
-
15
Cardiovascular toxicities associated with immune checkpoint inhibitors Autor Jiun‐Ruey Hu, Roberta Florido, Evan J. Lipson, Jarushka Naidoo, Reza Ardehali, Carlo G. Tocchetti, Alexander R. Lyon, Robert F. Padera, Douglas B. Johnson, Javid J. Moslehi
Vydáno 2019Revisão -
16
-
17
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series Autor Kendall F. Moseley, Jarushka Naidoo, Clifton O. Bingham, Michael A. Carducci, Patrick M. Forde, Geoffrey T. Gibney, Evan J. Lipson, Ami A. Shah, William H. Sharfman, Laura C. Cappelli
Vydáno 2018Artigo -
18
Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point<sup>18</sup>F-FDG PET/CT Imaging in Patients with Advanced Melanoma Autor Steve Y. Cho, Evan J. Lipson, Hyung‐Jun Im, Steven P. Rowe, Esther Mena Gonzalez, Amanda L. Blackford, Alin Chirindel, Drew M. Pardoll, Suzanne L. Topalian, Richard L. Wahl
Vydáno 2017Artigo -
19
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation Autor Tawnie Braaten, Julie R. Brahmer, Patrick M. Forde, Dung T. Le, Evan J. Lipson, Jarushka Naidoo, Megan D. Schollenberger, Lei Zheng, Clifton O. Bingham, Ami A. Shah, Laura C. Cappelli
Vydáno 2019Artigo -
20
PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival Autor Evan J. Lipson, Jeremy Vincent, Myriam Loyo, Luciane T. Kagohara, Brandon Luber, Hao Wang, Haiying Xu, Suresh K. Nayar, Timothy S. Wang, David Sidransky, Robert A. Anders, Suzanne L. Topalian, Janis M. Taube
Vydáno 2013Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Immunotherapy
Cancer
Oncology
Cancer research
Immunology
Immune system
Melanoma
Biology
Immune checkpoint
Nivolumab
Adverse effect
Ipilimumab
Pathology
Biochemistry
Carcinoma
Pembrolizumab
Merkel cell carcinoma
Blockade
Chemotherapy
Disease
Gastroenterology
Receptor
Antibody
Biomarker
CD8
Clinical trial
Gene
Surgery